A clinical review of recent findings in the epidemiology of inflammatory bowel disease

Clinical Epidemiology

Volumn 5, Issue 1, 2013, Pages 237-247

  Ponder, Alexis ^a   Long, Millie D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical epidemiology; Environmental risk factors; Inflammatory bowel disease

Indexed keywords

ANTIBIOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; VITAMIN D;

AGE DISTRIBUTION; BREAST FEEDING; CROHN DISEASE; DIET; DRUG USE; ENTERITIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GASTROENTERITIS; GASTROINTESTINAL INFECTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; GEOGRAPHIC DISTRIBUTION; HELICOBACTER PYLORI; HELMINTH; HIGH RISK POPULATION; HUMAN; HYGIENE; INCIDENCE; INFECTION RISK; INTESTINE FLORA; LIFESTYLE; MOOD; ORAL CONTRACEPTIVE USE; PATHOGENESIS; PREVALENCE; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SOCIOECONOMICS; STRESS; ULCERATIVE COLITIS;

EID: 84880790074     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S33961     Document Type: Review

References (102)

1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142;46-54 e42; quiz e30.
2. Ng SC, Bernstein CN, Vatn MH, et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62; 630-649.
3. Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease; a systematic review of international trends. Inflamm Bowel Dis. 2011;17;423-439.
4. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease; Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126;1504-1517.
5. Bernstein CN, Shanahan F. Disorders of a modern lifestyle; reconciling the epidemiology of inflammatory bowel diseases. Gut. 2008;57; 1185-1191.
6. Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia; a systematic review. J Gastroenterol Hepatol. 2012;27;1266-1280.
7. Malmborg P, Grahnquist L, Lindholm J, Montgomery S, Hildebrand H. Increasing incidence of paediatric inflammatory bowel disease in Northern Stockholm County 2002-2007. J Pediatr Gastroenterol Nutr. Epub March 1, 2013.
8. Grieci T, Butter A. The incidence of inflammatory bowel disease in the pediatric population of Southwestern Ontario. J Pediatr Surg. 2009;44; 977-980.
9. Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF. A populationbased case control study of potential risk factors for IBD. Am J Gastroenterol. 2006;101;993-1002.
10. Perminow G, Brackmann S, Lyckander LG, et al. A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005-2007, showing increased incidence in Crohn's disease. Scand J Gastroenterol. 2009;44;446-456.
11. Lehtinen P, Ashorn M, Iltanen S, et al. Incidence trends of pediatric inflammatory bowel disease in Finland, 1987-2003, a nationwide study. Inflamm Bowel Dis. 2011;17;1778-1783.
12. Pinsk V, Lemberg DA, Grewal K, Barker CC, Schreiber RA, Jacobson K. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol. 2007;102;1077-1083.
13. Probert CS, Jayanthi V, Pinder D, Wicks AC, Mayberry JF. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut. 1992;33;687-693.
14. Barreiro-de Acosta M, Alvarez Castro A, Souto R, Iglesias M, Lorenzo A, Dominguez-Munoz JE. Emigration to western industrialized countries; A risk factor for developing inflammatory bowel disease. J Crohns Colitis. 2011;5;566-569.
15. Benchimol EI, Guttmann A, Griffiths AM, et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada; evidence from health administrative data. Gut. 2009;58;1490-1497.
16. Fleischer DE, Grimm IS, Friedman LS. Inflammatory bowel disease inolder patients. Med Clin North Am. 1994;78;1303-1319.
17. Grimm IS, Friedman LS. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am. 1990;19;361-389.
18. Lashner BA, Kirsner JB. Inflammatory bowel disease in older people. Clin Geriatr Med. 1991;7;287-299.
19. Lindner AE. Inflammatory bowel disease in the elderly. Clin Geriatr Med. 1999;15;487- 497.
20. Robertson DJ, Grimm IS. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am. 2001;30;409-426.
21. Softley A, Myren J, Clamp SE, et al. Inflammatory bowel disease in the elderly patient. Scand J Gastroenterol Suppl. 1988;144;27-30.
22. Ananthakrishnan AN, Binion DG. Treatment of ulcerative colitis in the elderly. Dig Dis. 2009;27(3);327-334.
23. Katz S, Pardi DS. Inflammatory bowel disease of the elderly; frequently asked questions (FAQs). Am J Gastroenterol. 2011;106; 1889-1897.
24. Cho JH, Brant SR. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology. 2011;140;1704-1712.
25. Denson LA, Long MD, McGovern DP, et al. Challenges in IBD Research; Update on Progress and Prioritization of the CCFA's Research Agenda. Inflamm Bowel Dis. 2013;19;677-682.
26. Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort; a long-term follow-up of concordance and clinical characteristics. Gastroenterology. 2003;124;1767-1773.
27. Brant SR. Update on the heritability of inflammatory bowel disease; the importance of twin studies. Inflamm Bowel Dis. 2011;17;1-5.
28. Halfvarson J. Genetics in twins with Crohn's disease; less pronounced than previously believed? Inflamm Bowel Dis. 2011;17;6-12.
29. Hugot JP, Cezard JP, Colombel JF, et al. Clustering of Crohn's disease within affected sibships. Eur J Hum Genet. 2003;11;179-184.
30. Laharie D, Debeugny S, Peeters M, et al. Inflammatory bowel disease in spouses and their offspring. Gastroenterology. 2001;120; 816-819.
31. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134;577-594.
32. Olszak T, An D, Zeissig S, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science. 2012;336; 489-493.
33. Round JL, Lee SM, Li J, et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science. 2011;332;974-977.
34. Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331;337-341.
35. Hviid A, Svanstrom H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut. 2011;60;49-54.
36. Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2010;6;339-346.
37. Castiglione F, Diaferia M, Morace F, et al. Risk factors for inflammatory bowel diseases according to the hygiene hypothesis; a case-control, multi-centre, prospective study in Southern Italy. J Crohns Colitis. 2012;6;324-329.
38. Baron S, Turck D, Leplat C, et al. Environmental risk factors in paediatric inflammatory bowel diseases; a population based case control study. Gut. 2005;54;357-363.
39. Klement E, Cohen RV, Boxman J, Joseph A, Reif S. Breastfeeding and risk of inflammatory bowel disease; a systematic review with meta-analysis. Am J Clin Nutr. 2004;80;1342-1352.
40. Barclay AR, Russell RK, Wilson ML, Gilmour WH, Satsangi J, Wilson DC. Systematic review; the role of breastfeeding in the development of pediatric inflammatory bowel disease. J Pediatr. 2009;155;421-426.
41. Khalili H, Ananthakrishnan AN, Higuchi LM, Richter JM, Fuchs CS, Chan AT. Early life factors and risk of inflammatory bowel disease in adulthood. Inflamm Bowel Dis. 2013;19;542-547.
42. Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol. 2010;25;325-333.
43. Hansen TS, Jess T, Vind I, et al. Environmental factors in inflammatory bowel disease; a case-control study based on a Danish inception cohort. J Crohns Colitis. 2011;5;577-584.
44. Fanaro S, Chierici R, Guerrini P, Vigi V. Intestinal microflora in early infancy; composition and development. Acta Paediatr Suppl. 2003;91; 48-55.
45. Midtvedt AC, Midtvedt T. Production of short chain fatty acids by the intestinal microflora during the first 2 years of human life. J Pediatr Gastroenterol Nutr. 1992;15;395-403.
46. Gradel KO, Nielsen H., Schonheyder HC, Ejlertsen T, Kristensen B, Nielsen H. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology. 2009;137;495-501.
47. Porter CK, Tribble DR, Aliaga PA, Halvorson HA, Riddle MS. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology. 2008;135;781-786.
48. Luther J, Dave M, Higgins PD, Kao JY. Association between Helicobacter pylori infection and inflammatory bowel disease; a metaanalysis and systematic review of the literature. Inflamm Bowel Dis. 2010;16;1077-1084.
49. Ram M, Barzilai O, Shapira Y, et al. Helicobacter pylori serology in autoimmune diseases - fact or fiction? Clin Chem Lab Med. 2012;0; 1-8.
50. Sonnenberg A, Genta RM. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2012;35;469-476.
51. Owyang SY, Luther J, Owyang CC, Zhang M, Kao JY. Helicobacter pylori DNA's anti-inflammatory effect on experimental colitis. Gut Microbes. 2012;3;168-171.
52. Elliott DE, Weinstock JV. Where are we on worms? Curr Opin Gastroenterol. 2012;28;551-556.
53. Hunter MM, McKay DM. Review article; helminths as therapeutic agents for inflammatory bowel disease. Aliment Pharmacol Ther. 2004; 19;167-177.
54. Chu KM, Watermeyer G, Shelly L, et al. Childhood helminth exposure is protective against inflammatory bowel disease; a case control study in South Africa. Inflamm Bowel Dis. 2013;19;614-620.
55. Blum AM, Hang L, Setiawan T, et al. Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses. J Immunol. 2012;189;2512-2520.
56. Walk ST, Blum AM, Ewing SA, Weinstock JV, Young VB. Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus. Inflamm Bowel Dis. 2010;16; 1841-1849.
57. Summers RW, Elliott DE, Urban JF Jr, Thompson R, Weinstock JV. Trichuris suis therapy in Crohn's disease. Gut. 2005;54;87-90.
58. Summers RW, Elliott DE, Urban JF Jr, Thompson RA, Weinstock JV. Trichuris suis therapy for active ulcerative colitis; a randomized controlled trial. Gastroenterology. 2005;128;825-832.
59. Kronman, M. P., Zaoutis, T. E., Haynes, K., Feng, R., Coffin, S. E. Antibiotic exposure and IBD development among children; a population-based cohort study. Pediatrics. 2012; 130;794-803.
60. Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol. 2010;105;2687-2692.
61. Virta L, Auvinen A, Helenius H, Huovinen P, Kolho KL. Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease - a nationwide, register-based finnish case-control study. Am J Epidemiol. 2012;175;775-784.
62. Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis. Am J Gastroenterol. 2011;106;2133-2142.
63. Khalili H, Higuchi LM, Ananthakrishnan AN, et al. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut. Epub June 1, 2012.
64. Cornish JA, Tan E, Simillis C, Clark SK, Teare J, Tekkis PP. The risk of oral contraceptives in the etiology of inflammatory bowel disease; a meta-analysis. Am J Gastroenterol. 2008;103;2394-2400.
65. Timmer, A., Sutherland, L.R., Martin, F., Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology. 1998;114;1143-1150.
66. Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Gendre JP. Oral contraceptive use and the clinical course of Crohn's disease; a prospective cohort study. Gut. 1999;45;218-222.
67. Zapata LB, Paulen ME, Cansino C, Marchbanks PA, Curtis KM. Contraceptive use among women with inflammatory bowel disease; A systematic review. Contraception. 2010;82;72-85.
68. Cipolla G, Crema F, Sacco S, Moro E, de Ponti F, Frigo G. Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease; current perspectives. Pharmacol Res. 2002;46;1-6.
69. Ananthakrishnan AN, Higuchi LM, Huang ES, et al. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis; a cohort study. Ann Intern Med. 2012;156;350-359.
70. Takeuchi K, Smale S, Premchand P, et al. Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4;196-202.
71. Bernstein CN, Singh S, Graff LA, Walker JR, Miller N, Cheang M. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol. 2010;105;1994-2002.
72. De Silva P, Ananthakrishnan AN. VitaminD and IBD; More pieces to the puzzle, still no complete picture. Inflamm Bowel Dis. 2012;18; 1391-1393.
73. Khalili H, Huang ES, Ananthakrishnan AN, et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut. 2012;61;1686-1692.
74. Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology. 2012;142;482-489.
75. Ulitsky A, Ananthakrishnan AN, Naik A, et al. Vitamin D deficiency in patients with inflammatory bowel disease; association with disease activity and quality of life. JPEN J Parenter Enteral Nutr. 2011;35;308-316.
76. Soon IS, Molodecky NA, Rabi DM, Ghali WA, Barkema HW, Kaplan GG. The relationship between urban environment and the inflammatory bowel diseases; a systematic review and meta-analysis. BMC Gastroenterol. 2012;12;51.
77. Haug K, Schrumpf E, Halvorsen JF, et al. Epidemiology of Crohn's disease in western Norway. Study group of Inflammatory Bowel Disease in Western Norway. Scand J Gastroenterol. 1989;24;1271-1275.
78. Kaplan GG, Hubbard J, Korzenik J, et al. The inflammatory bowel diseases and ambient air pollution; a novel association. Am J Gastroenterol. 2010;105;2412-2419.
79. Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. Ambient air pollution correlates with hospitalizations for inflammatory bowel disease; an ecologic analysis. Inflamm Bowel Dis. 2011;17;1138-1145.
80. Sonnenberg A. Occupational distribution of inflammatory bowel disease among German employees. Gut. 1990;31;1037-1040.
81. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci. 1989;34;1841-1854.
82. Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease; a meta-analysis. Mayo Clin Proc. 2006;81;1462-1471.
83. Higuchi LM, Khalili H, Chan AT, Richter JM, Bousvaros A, Fuchs CS. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol. 2012;107; 1399-1406.
84. Cosnes J. Tobacco and IBD; relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol. 2004;18;481-496.
85. Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Cattan S, Gendre J. Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther. 1999;13;1403-1411.
86. Cosnes J. Smoking, physical activity, nutrition and lifestyle; environmental factors and their impact on IBD. Dig Dis. 2010;28;411-417.
87. Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis. 2004;10; 646-651.
88. Chapman-Kiddell CA, Davies PS, Gillen L, Radford-Smith GL. Role of diet in the development of inflammatory bowel disease. Inflamm Bowel Dis. 2010;16;137-151.
89. Zallot C, Quilliot D, Chevaux JB, et al. Dietary beliefs and behavior among inflammatory bowel disease patients. Inflamm Bowel Dis. 2013;19;66-72.
90. Silkoff K, Hallak A, Yegena L, et al. Consumption of refined carbohydrate by patients with Crohn's disease in Tel-Aviv-Yafo. Postgrad Med J. 1980;56;842-846.
91. Kasper H, Sommer H. Dietary fiber and nutrient intake in Crohn's disease. Am J Clin Nutr. 1979;32;1898-1901.
92. Gentschew L, Ferguson LR. Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Mol Nutr Food Res. 2012;56; 524-535.
93. Tjonneland A, Overvad K, Bergmann MM, et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis; a nested case-control study within a European prospective cohort study. Gut. 2009;58;1606-1611.
94. D'Souza S, Levy E, Mack D, et al. Dietary patterns and risk for Crohn's disease in children. Inflamm Bowel Dis. 2008;14;367-373.
95. Ananthakrishnan AN. Environmental triggers for inflammatory bowel disease. Curr Gastroenterol Rep. 2013;15;302.
96. Lerebours E, Gower-Rousseau C, Merle V, et al. Stressful life events as a risk factor for inflammatory bowel disease onset; A populationbased case-control study. Am J Gastroenterol. 2007;102;122-131.
97. Ananthakrishnan AN, Khalili H, Pan A, et al. Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis; results from the Nurses' Health Study. Clin Gastroenterol Hepatol. 2013;11;57-62.
98. Sajadinejad MS, Asgari K, Molavi H, Kalantari M, Adibi P. Psychological issues in inflammatory bowel disease; an overview. Gastroenterol Res Pract. 2012;2012;106502.
99. Hollander D. Inflammatory bowel diseases and brain-gut axis. J Physiol Pharmacol. 2003;54 Suppl 4;183-190.
100. Rampton DS. The influence of stress on the development and severity of immune-mediated diseases. J Rheumatol Suppl. 2011;88;43-47.
101. Levenstein S, Prantera C, Varvo V, et al. Stress and exacerbation in ulcerative colitis; a prospective study of patients enrolled in remission. Am J Gastroenterol. 2000;95;1213-1220.
102. Ananthakrishnan AN, Gainer VS, Perez RG, et al. Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's disease. Aliment Pharmacol Ther. 2013;37;445-454.